Especially the microglial-specific inhibition of TAK1 seems to dampen post-ischemic neuroinflammation sustainably and improve neurological outcome after stroke indicating that microglia exert detrimental pro-inflammatory and pro-apoptotic effects in the early phase after ischemia. Here, MAP3K7 is linked to ischemia.